+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 18Years - 60Years
All Genders
ID06327451

Study of Atorvastatin Combined With Temozolomide to Treat Glioblastoma with High EGFR Expression Phase II Trial Evaluating Safety and Effectiveness in Adults 18 to 60 Years Old

Led by Tianjin Medical University General Hospital · Updated on 2024-03-25

50

Participants Needed

1

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

Glioblastoma GBM is a severe brain tumor with high rates of illness and death, and a 5-year survival rate below 10%. In China, GBM leads in new diagnoses and deaths annually, posing a serious health risk. Current treatments combining surgery, chemotherapy, radiotherapy, and tumor treating fields TTF have limited success, with median survival around 14.4 months. Statins, commonly used to lower cholesterol, have shown potential anti-tumor effects, including blocking glioma progression via the EGFR pathway. This study aims to evaluate how well atorvastatin combined with temozolomide works in patients with GBM that highly expresses EGFR. This is a multicenter, single-arm, double-blind phase II trial where participants receive standard STUPP regimen treatment plus oral atorvastatin 20 mg once daily starting two weeks after glioma surgery. The study lasts for 52 weeks, during which patients are regularly monitored. The main goal is to assess progression-free survival time until tumor growth or death. Secondary goals include tumor control rate and overall survival. Safety assessments include MRI scans, blood tests for liver function and lipids, electrocardiograms, vital signs, and weight monitoring. Participants will be followed closely with scheduled visits and evaluations throughout the 52-week period. Researchers will measure tumor progression, survival, and tumor size changes to understand treatment effects. Safety will be monitored continuously through clinical and laboratory tests. Results from this trial will provide important information on whether combining atorvastatin with temozolomide can safely extend progression-free survival in patients with EGFR-high glioblastoma.

CONDITIONS

Brief Title

Evaluate the Efficacy and Safety of Atorvastatin Combined With Temozolomide in the Treatment of Glioblastoma

Research Team

C

Chunsheng Kang

X

Xiaoteng Cui

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here